Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MECP2 mutations disrupt pluripotent stem cell fate through remodeling of the three-dimensional genome.

Cell death & disease·2026
Same author

Enhanced early detection of thyroid cancer using ensemble machine learning and serum proteomics.

Frontiers in oncology·2026
Same author

TRIM35, a novel DNA-binding protein, epigenetically modifies H3 to promote HSPA6 transcription and suppress breast cancer progression.

Cell death discovery·2025
Same author

Volume Pre-Allocation Strategy for Enhancing Formability and Die Life in AISI-410 Martensitic Stainless Steel U-Shaped Forgings.

Materials (Basel, Switzerland)·2025
Same author

MeCP2 dysregulation inhibits mitophagy and impairs neural development in cortical organoids.

Journal of advanced research·2025
Same author

The impact of US tariff hikes on health care.

Lancet (London, England)·2025

Related Experiment Video

Updated: Jun 24, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Integrated Machine Learning Algorithms-Enhanced Predication for Cervical Cancer from Mass Spectrometry-Based

Da Zhang1, Lihong Zhao2, Bo Guo3

  • 1Department of Oncology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710000, China.

Bioengineering (Basel, Switzerland)
|March 28, 2025
PubMed
Summary

Artificial intelligence (AI) and machine learning (ML) applied to serum proteomics data improve early cervical cancer diagnosis. This AI-driven approach enhances biomarker identification, significantly boosting diagnostic accuracy for better patient outcomes.

Keywords:
artificial intelligencecervical cancerearly diagnosisproteomics

More Related Videos

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 24, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

Area of Science:

  • Biomarker Discovery
  • Artificial Intelligence in Oncology
  • Proteomics and Machine Learning

Background:

  • Early cancer diagnosis is crucial for patient outcomes but faces challenges with serum proteomic markers.
  • Artificial intelligence (AI), including machine learning (ML), offers advanced analytical capabilities for complex biological data.

Purpose of the Study:

  • To develop an AI-driven pipeline for identifying and validating serum biomarkers for early cervical cancer (CC) diagnosis.
  • To leverage mass spectrometry-based proteomics data combined with ML for enhanced diagnostic performance.

Main Methods:

  • Processed and normalized serum polypeptide differential peaks from 240 cervical cancer patients.
  • Employed eight distinct ML algorithms for classification and analysis of proteomic data.
  • Utilized feature importance, Shapley values, and LIME for model interpretability and validation.

Main Results:

  • AI-driven multi-dimensional learning models achieved a diagnostic area under the curve (AUC) approaching 1.
  • Performance metrics (accuracy, precision, recall, F1 score) were systematically evaluated.
  • The integrated ML approach significantly outperformed the diagnostic AUC of single markers from the PRIDE database.

Conclusions:

  • Proteomics-driven integrated machine learning presents a robust strategy for enhancing early cancer diagnosis.
  • The developed AI pipeline shows significant potential for clinical translation in improving cancer detection rates.